All Stories

  1. Glucagon-like peptide 1 receptor activation: anti-inflammatory effects in the brain
  2. Anti-Inflammatory Effects of GLP-1 Receptor Activation in the Brain in Neurodegenerative Diseases
  3. Renin–Angiotensin System in Liver Metabolism: Gender Differences and Role of Incretins
  4. GLP-1 receptor agonist ameliorates experimental lung fibrosis
  5. Liraglutide Enhances the Activity of the ACE-2/Ang(1–7)/Mas Receptor Pathway in Lungs of Male Pups from Food-Restricted Mothers and Prevents the Reduction of SP-A
  6. Incretins activate the corticoadrenal axis
  7. Emotional behavior is modulated by liragutide in an age and gender manner in rats from food restriction mothers
  8. Liraglutide increases surfactant proteins (SPA & SPB) and angiotensin-converting enzymes (ACE & ACE2) expression in a rat model of acute lung injury by bleomycin
  9. Liraglutide restores the endocrine function of islet's [beta]-cells and the altered lipid profile in early stages of life induced by food restriction in pregnancy
  10. GLP-1 Increases Preovulatory LH Source and the Number of Mature Follicles, As Well As Synchronizing the Onset of Puberty in Female Rats
  11. Activation of the GLP-1 Receptor by Liraglutide Increases ACE2 Expression, Reversing Right Ventricle Hypertrophy, and Improving the Production of SP-A and SP-B in the Lungs of Type 1 Diabetes Rats
  12. Clinical characterisation of acromegaloidism in a controlled prospective study
  13. Glp-1 regulates the reproductive function and synchronizes the onset of the puberty in female rats
  14. Liraglutide improves surfactant protein-B production and reduces right ventricular hypertrophy in a rat model of intersitial pulmonary fibrosis
  15. Corticotropin-Releasing Hormone and the Sympathoadrenal System Are Major Mediators in the Effects of Peripherally Administered Exendin-4 on the Hypothalamic-Pituitary-Adrenal Axis of Male Rats
  16. Effects of prolonged exendin-4 administration on hypothalamic-pituitary-adrenal axis activity and water balance
  17. Pulmonary GLP-1 Receptor Increases at Birth and Exogenous GLP-1 Receptor Agonists Augmented Surfactant-Protein Levels in Litters From Normal and Nitrofen-Treated Pregnant Rats
  18. Subcutaneous Administration of Exenatide Increases Nocturnal Cortisol Levels in Saliva of Type 2 Diabetic Patients
  19. GLP-1(7-36)-amide and Exendin-4 Stimulate the HPA Axis in Rodents and Humans
  20. Glucagon-Like Peptide-1 (7-36)-Amide and Exendin-4 Strongly Stimulate the Hypothalamic-Pituitary-Adrenal Axis in Rodents and in Healthy or Diabetic Humans
  21. Exendin-4 increases blood glucose levels acutely in rats by activation of the sympathetic nervous system
  22. Las hormonas gastrointestinales en el control de la ingesta de alimentos
  23. Prolactin-releasing peptide (PrRP) increases prolactin responses to TRH in vitro and in vivo
  24. Ghrelin improves growth hormone responses to growth hormone-releasing hormone in a streptozotocin-diabetic model of delayed onset
  25. Growth hormone distribution kinetics are markedly reduced in adults with growth hormone deficiency
  26. Exendin-4 Potently Decreases Ghrelin Levels in Fasting Rats
  27. Gut Hormones Ghrelin, PYY, and GLP-1 in the Regulation of Energy, Balance, and Metabolism
  28. Fibroblast Growth Factor-2 and Epidermal Growth Factor Modulate Prolactin Responses to TRH and Dopamine in Primary Cultures
  29. Heparin Increases Prolactin and Modifies the Effects of FGF-2 Upon Prolactin Accumulation in Pituitary Primary Cultures
  30. GH responses to GHRH and GHRP-6 in Streptozotocin (STZ)-diabetic rats
  31. Altered GH Elimination Kinetics in Type 1 Diabetes Mellitus Can Explain the Elevation in Circulating Levels: Bicompartmental Approach
  32. Regulation of hypothalamic somatostatin and growth hormone releasing hormone mRNA levels by inhibin
  33. Growth Hormone (GH) Response to GH-Releasing Peptide-6 in Type 1 Diabetic Patients with Exaggerated GH-Releasing Hormone-Stimulated GH Secretion1
  34. Inhibin Suppresses in vivo Growth Hormone Secretion
  35. Retinoic acid inhibits in vivo thyroid-stimulating hormone secretion
  36. Influence of endogenous cholinergic tone and growth hormone-releasing peptide-6 on exercise induced growth hormone release
  37. Plasma growth hormone response to growth hormone-releasing hexapeptide (GH-RP-6) in children with short stature
  38. Metabolic clearance rate of biosynthetic growth hormone after endogenous growth hormone suppression with a somatostatin analogue in chronic renal failure patients and control subjects
  39. Regulation of His-dTrp-Ala-Trp-dPhe-Lys-NH2 (GHRP-6)-lnduced GH Secretion in the Rat
  40. Effect of neurotensin on growth hormone release in vivo
  41. Regulation of Growth Hormone Secretion by the Growth Hormone Releasing Hexapeptide (GHRP-6)
  42. Effect of Retinoic Acid Deficiency on in vivo and in vitro GH Responses to GHRH in Male Rats
  43. Evidence for a Direct Pituitary Inhibition by Free Fatty Acids of in vivo Growth Hormone Responses to Growth Hormone-Releasing Hormone in the Rat
  44. Estrogen-Dependent Effects of Bombesin on in vivo Growth Hormone Secretion in the Rat